NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
November 15, 2021 at 01:55 pm IST
Share
NEXTURNBIOSCIENCE Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was KRW 32.97 million compared to KRW 25.24 million a year ago. Net loss was KRW 1,508.38 million compared to KRW 855.4 million a year ago. Basic loss per share from continuing operations was KRW 47 compared to KRW 80 a year ago. Diluted loss per share from continuing operations was KRW 47 compared to KRW 80 a year ago. Basic loss per share was KRW 47 compared to KRW 80 a year ago.
For the nine months, sales was KRW 90.68 million compared to KRW 99.68 million a year ago. Net loss was KRW 5,899.96 million compared to net income of KRW 783.76 million a year ago. Basic loss per share from continuing operations was KRW 184 compared to basic earnings per share from continuing operations of KRW 73 a year ago. Diluted loss per share from continuing operations was KRW 184 compared to diluted earnings per share from continuing operations of KRW 73 a year ago. Basic loss per share was KRW 184 compared to basic earnings per share of KRW 73 a year ago.
NexturnBioScience Co Ltd, formerly Nexturn Co Ltd, is a Korea-based company principally engaged in the manufacture and sale of computer numerical control (CNC) automatic lathes. The Company's products are used for automobile parts such as engine parts, steering devices, wipers and others, marine engine parts, medical devices and implants, communication equipment such as mobile phones, digital multimedia broadcasting (DMB) devices and others, electronic components such as liquid crystal display (LCD), copier, printer and others, hydraulic and pneumatic parts, among others. It also provides related parts, after-sales service.
NEXTURNBIOSCIENCE CO., LTD. 
